Pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease: National cohort study

Chieh Li Yen, Chao Yi Wu, Lai Chu See, Yi Jung Li, Min Hua Tseng, Wei Sheng Peng, Jia Rou Liu, Yung Chang Chen, Tzung Hai Yen, Ya Chung Tian, Chih Wei Yang, Gerard F. Anderson, Huang Yu Yang

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e152-e153
JournalDiabetes care
Issue number10
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this